Both Cpt1a (Figure 3D) and Cpt2 (Figure 3E) were significantly reduced in the KO-HF male group compared to the WT-HF group, with a significant recovery in Cpt2 expression with EPA supplementation in the KO group (Figure 3E). The gene discussed is CPT2; the disease is hydrops fetalis.